Remarkably, in all three patients, NR4A3 expression levels were relatively higher after the ATRA leukemia cell differentiation treatments (Fig. 4B), whereas the expression levels of NR4A1 were not consistently or overtly altered. Here, NR4A3 is linked to leukemia.